Subscribe To
Goldman sachs maintains erasca buy recommendation
Fintel reports that on May 16, 2023, Goldman Sachs maintained coverage of erasca (NASDAQ:ERAS) with a B...
May 16, 2023, 10:34 pm
erasca announces two poster presentations at the 2023 asco annual meeting
Posters will feature preliminary Phase 1b combination data for potential best-in-class ERK1/2 inhibitor ERAS-007 with encorafenib and cetuximab or wit...
April 26, 2023, 9:00 pm
erasca: potential strong upside ahead
erasca, Inc. is a clinical-stage biopharmaceutical developer of therapies for patients with RAS/MAPK pa...
February 8, 2023, 11:21 am
erasca to present at the guggenheim oncology conference 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision on...
February 1, 2023, 8:00 am
erasca to present at the 41st annual j.p. morgan healthcare conference
SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision on...
January 4, 2023, 8:00 am
erasca announces exclusive worldwide license for pan-raf inhibitor naporafenib
Concurrent $100 million equity offering Naporafenib has a potential first-in-class and best-in-class profile in multiple RAS/MAPK pathway-driven tumor...
December 9, 2022, 12:34 pm
erasca announces pricing of underwritten offering of common stock
SAN DIEGO, Dec. 09, 2022 (GLOBE NEWSWIRE) — erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision o...
December 9, 2022, 12:32 pm
erasca to present at the morgan stanley global healthcare conference
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) -- erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision o...
September 9, 2022, 8:31 am
Is a surprise coming for erasca (eras) this earnings season?
erasca (ERAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings...
February 8, 2022, 10:45 am
Is a surprise coming for erasca (eras) this earnings season?
erasca (ERAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings...
February 8, 2022, 10:45 am
Is a surprise coming for erasca (eras) this earnings season?
erasca (ERAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings...
February 8, 2022, 10:45 am
erasca to present at the guggenheim healthcare talks 2022 oncology day
SAN DIEGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision on...
February 3, 2022, 8:00 am
erasca to present at the guggenheim healthcare talks 2022 oncology day
SAN DIEGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision on...
February 3, 2022, 8:00 am
erasca to present at the guggenheim healthcare talks 2022 oncology day
SAN DIEGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision on...
February 3, 2022, 8:00 am